Ordopidine, formerly known as ACR325, is a dopaminergic stabilizer. Ordopidine inhibits psychostimulant-induced hyperactivity, and stimulates behaviour in states of hypoactivity. Ordopidine acts as dopamine D2 receptor antagonists in vitro, albeit with low affinity, their specific state-dependent behavioural effect profile is not shared by D2 receptor antagonists in general. References: Waters S, Ponten H, Edling M, Svanberg B, Klamer D, Waters N. The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression. J Neural Transm (Vienna). 2014 Nov;121(11):1337-47. doi: 10.1007/s00702-014-1231-1. Epub 2014 May 11. PubMed PMID: 24817271.

纯度：≥98%

CAS：871351-60-9